ReOxy therapy is a unique patented rehabilitation method (IHHT® – Interval Hypoxia Hyperoxia Training) based on usage of positive cell protection molecular mechanisms that are triggered in response to changes in oxygen levels.

By using reduced and enriched oxygen gas mixtures, a ReOxy treatment leads to more efficient transport and utilization of O2 by body tissues.

A method based on more then 10 years of research and clinical trials (the discovery of HIF-1a and its implication in oxygen adaptation was awarded the Nobel prize in medicine 2019).

A non-pharmaceutical treatment with minimal side-effects.

A unique solution for athletes, elderly/senior patients and patients with reduced physical abilities.

The therapeutic effect of ReOxy® treatment relies upon the body’s physiological adaptive response to repeated mild short-term hypoxia (10-15% O2) and short-term hyperoxia (30-40% O2).

Hypoxic and Hyperoxic breathing gas mixtures are supplied via the facial mask.

The switch between gas mixtures is performed automatically, controlled by AI biofeedback principle using SRT® technology.

One procedure lasts for 45-60 minutes each.

At the end of procedure ReOxy generates a summary report updated with each session.

The recommended treatment course is 15-20 procedures over a 1-3 month period.

Sit, breathe, relax and obtain the benefits – it’s that simple.

The programs are automated and personalized, adapting to personal capacity.

The training program is based on short periods of controlled hypoxia with intermittent recovery intervals of hyperoxia.

1. Sit down and put on finger sensor and the mask – the method painless and drug free.
2. Breathe normally and our AI powered software calculates the best training program for you.
3. The program starts – the positive effects reach your entire body including the nervous system, cardiovascular system, respiratory system, bones and joints and metabolism.
4. After your session, you can perform all your normal activities without any restrictions.

ReOxy makes safe hypoxia accessible.

The device has been subjected to multiple clinical tests in which no severe secondary effects were reported.

ReOxy has been approved for medical and non-medical use in Australia and around the world.